Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-10

Clinical Trial Update: A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completed Phase 1/Phase 2 study evaluating the safety and efficacy of Lessertia Frutescens in HIV-infected adults in South Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lessertia Frutescens (Lessertia Frutescens)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED